A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.

NCT00806260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: VI-0521
DRUG: Placebo
OTHER: Alcohol
OTHER: alcohol placebo

Sponsor

VIVUS LLC

Collaborators

[object Object]